AIM ImmunoTech Inc. (AIM)

Health Care·equity

$0.18

+0.22% today

Prices delayed about 15 minutes · cached page, can be an hour old or more

Market Census Score

27/ 100

Score level

Below average

6 of 6 checks had data

How it compares with the broader market is one of its lowest-scoring factors; price trend is one of its lowest-scoring factors; and business numbers score is on the low side.

AIM scores higher than 24% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, AIM ImmunoTech Inc. (AIM) scores 27 out of 100 on the Market Census six-factor composite, which puts it at the Below average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated 9 October 2026 · scores usually change about once a day

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume: 0.05× 30-day average
52-week range: 0.17 – 2.88
Market cap: $7.37M
Earnings date: 16 Nov 2026

Volume: 409,932
Avg. volume (30d): 8,753,056

Open: 0.18
Previous close: 0.18
Day's range (regular session): 0.18 – 0.18

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta: 1.34
P/E (TTM): —
EPS (TTM): -3.93

Score breakdown · six named factors

Price trend

Strength vs the market

Company finances

Insider trades

Market mood

Recent momentum

Each bar is one part of the score, from 0 to 100. Read what the score means.

Premium data held for AIM

4 SEC Form 4 insider transactions in the last 90 daysPremium

Counts of rows Market Census holds for AIM. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans

What the score says about AIM right now

AIM ImmunoTech Inc. (AIM) currently scores 27/100 on the Market Census six-factor composite, at the Below average score level. AIM is +0.22% on the day and +0.00% over five sessions as of the most recent tick. Below average sits a bit below the middle. More of AIM's data reads poorly than well. The level is a "look before you act" flag. It is not advice. AIM's strongest factor is insider trades at 90/100 — a very strong read on insider buying and selling. Insider filings currently lean toward buying on this name — a plain read of public filings, not a signal to follow. The weakest factor is strength vs the market at 0/100 — well below average next to the wider market.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See AIM in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Create your account →Share on X Embed this score